Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia
- PMID: 3258144
- PMCID: PMC172106
- DOI: 10.1128/AAC.32.1.96
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia
Abstract
Inhibitors of folic acid synthesis were compared alone and in different combinations in the therapy of pneumocystosis in immunosuppressed rats. Sulfonamides (sulfamethoxazole, sulfadiazine, and sulfadoxine) and sulfones (dapsone) used alone were very active against Pneumocystis carinii, as judged by histologic examination of the lungs and by organism quantitation. Improved efficacy could not be demonstrated by the addition of an inhibitor of dihydrofolate reductase to the regimen. Dihydrofolate reductase inhibitors (trimethoprim, diaveridine, and pyrimethamine) used alone were ineffective against P. carinii. All drugs were well tolerated except pyrimethamine, which caused bone marrow depression; folinic acid ameliorated this adverse reaction but did not interfere with P. carinii treatment. These data have potential clinical implications but need to be interpreted with caution and in light of other systems of P. carinii drug evaluation.
Similar articles
-
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.Antimicrob Agents Chemother. 1996 Sep;40(9):2067-70. doi: 10.1128/AAC.40.9.2067. Antimicrob Agents Chemother. 1996. PMID: 8878582 Free PMC article.
-
Pneumocystis carinii pneumonia: therapy and prophylaxis.J Infect Dis. 1988 Jul;158(1):254-9. doi: 10.1093/infdis/158.1.254. J Infect Dis. 1988. PMID: 2969023 Review. No abstract available.
-
Prevention of Pneumocystis carinii pneumonia.Med Lett Drugs Ther. 1988 Oct 7;30(776):94-5. Med Lett Drugs Ther. 1988. PMID: 3050408 Review. No abstract available.
-
Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumonia.Am J Trop Med Hyg. 1988 Nov;39(5):491-6. doi: 10.4269/ajtmh.1988.39.491. Am J Trop Med Hyg. 1988. PMID: 2973755
-
Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.Antimicrob Agents Chemother. 1993 Jul;37(7):1436-43. doi: 10.1128/AAC.37.7.1436. Antimicrob Agents Chemother. 1993. PMID: 8363372 Free PMC article.
Cited by
-
Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.Antimicrob Agents Chemother. 1991 Feb;35(2):252-5. doi: 10.1128/AAC.35.2.252. Antimicrob Agents Chemother. 1991. PMID: 2024957 Free PMC article.
-
Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?Thorax. 2000 Aug;55 Suppl 1(Suppl 1):S15-22. doi: 10.1136/thorax.55.suppl_1.s15. Thorax. 2000. PMID: 10943633 Free PMC article. Review. No abstract available.
-
Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.Proc Natl Acad Sci U S A. 1990 Aug;87(15):5950-4. doi: 10.1073/pnas.87.15.5950. Proc Natl Acad Sci U S A. 1990. PMID: 2198575 Free PMC article.
-
Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.J Fungi (Basel). 2022 Jan 27;8(2):129. doi: 10.3390/jof8020129. J Fungi (Basel). 2022. PMID: 35205883 Free PMC article. Review.
-
Fractionation of Pneumocystis carinii developmental stages by counterflow centrifugal elutriation and sequential filtrations.Parasitol Res. 1994;80(1):1-9. doi: 10.1007/BF00932616. Parasitol Res. 1994. PMID: 8153118
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources